Article
Activating mutations affecting the NF-kappa B pathway and EZH2-mediated epigenetic regulation are rare events in primary mediastinal large B-cell lymphoma.
Anticancer research - 1 Oct 2014
Gebauer Niklas, Hardel Tim Tristan, Gebauer Judith, Bernard Veronica, Merz Hartmut, Feller Alfred C, Rades Dirk, Biersack Harald, Lehnert Hendrik, Thorns Christoph
Abstract excerpt
BACKGROUND: Primary mediastinal large B-cell lymphoma (PMBL) is a distinct subtype of diffuse large B-cell lymphoma (DLBCL) frequently observed in young patients. High-dose immunochemotherapy constitutes the current therapeutic gold-standard, despite significant toxicity and serious late effects. Several hotspots harboring oncogenic gain-of-function mutations were recently shown to pose vital hallmarks in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
